Skip to main content
AAE25 Main banner
Be a Root Canal Rock Star! The stage is set - EdgeEndo at Booth 1201. Let's Rock!
Endodontic Practice Partners - Exclusively Endodontics. Our specialty is YOU
Endo Mastery Quickfire Breakouts in Booth #1001
Specialized Dental Partners - Visit AAE Booth #315 - Imagine More with the Power of Partnership
Back

Endo Plus

EP-1 - Substance Use Disorders: Implications for Endodontic Practice

Thursday, April 3, 2025
4:30 PM – 5:30 PM EST
Location: Hynes Convention Center, Floor 2, Room 200
Earn 1.0 CE Credits
Not Recorded
Disclosure(s):
Karen A. Baker, B.S., M.S.: No financial relationships to disclose
Mark A. Odom, D.D.S.: No financial relationships to disclose
Substance Use Disorders (SUDs) are unfortunately both common and destructive in our society. Karen will discuss new developments in the neurophysiology and treatment of common SUDs. Dental opioid prescribing has dramatically declined since 2015 and we’ll discuss opioid-sparing analgesia in Endodontics. Recreational marijuana is currently legal in 24 states and initiatives are underway in many more states. Karen will review the pharmacology of cannabis products and discuss oral effects and dental treatment ramifications for patients who frequently use cannabinoids with special emphasis on risks of high potency THC among adolescents. Non-opioid SUDs will be examined with the goal of recognizing recent use, oral effects and modifying treatment to ensure patient safety and avoid medicolegal complications. A detailed handout will enhance the take home value of this timely and important information.

Learning Objectives:

  • Describe the brain development stages and mental health disorders that predispose to SUDs
  • Outline strategies to maximize dental analgesia while minimizing the use of opioids
  • List the dental pain management and anesthesia implications of chronic cannabis use